Skip to main content
. 2022 Nov 17;9:1046560. doi: 10.3389/fcvm.2022.1046560

TABLE 1.

Characteristics of the participants and interventions.

References Sample size (sex) Intervention Participants characteristics Age (years) BMI (kg/m2) Exercise program duration, type, and frequency Intervention protocol (HIIT or SIT vs. MICT and CON) Total minutes of high-intensity bouts per session and week Total minutes of HIIT vs. MICT per week (min)
Abdi et al. (62) 30 (female) HIIT
CON
Type 2 diabetes HIIT: 20−44
CON: 20−44
HIIT: 29.2 ± 1.3
CON: 28.7 ± 1.5
12 weeks treadmill running; unsupervised 3 days/week HIIT: four sets of 4-min at 85–95% of HRmax with 3-min recovery at 50–60% of HRmax
CON: maintained the activities of daily living without any training program
16 (48) NA
Almenning et al. (63) 20 (female) HIIT
CON
Polycystic ovary syndrome HIIT: 27.2 ± 5.5
CON: 27.2 ± 5.5
HIIT: 26.1 ± 6.5
CON: 26.5 ± 5.0
10 weeks treadmill or outdoor walking/running and/or cycling; supervised 1 day/week; unsupervised 2 day/week HIIT: four sets of 4-min at 90–95% of HRmax with 3-min recovery at 70% of HRmax (2 sessions) + SIT: ten sets of 1-min at maximal intensity by 1-min recovery (1 session)
CON: without any structure program
14 (42) NA
Angadi et al. (44) 19 (male, female) HIIT
MICT
Heart failure HIIT: 69.0 ± 6.1
MICT: 71.5 ± 11.7
HIIT: 29.8 ± 5.1
MICT: 29.3 ± 2.8
4 weeks treadmill training; unsupervised 3 days/week HIIT: four sets of 2–4 min at 80–90% of HRpeak with 2–3 min recovery at 50% of HRpeak
MICT (not matched-work with HIIT): 15–30 min at 60–70% of HRpeak
16 (48) 48–85 vs. 45–90
Baekkerud et al. (45) 30 (male, female) HIIT1
HIIT2
MICT
Obese and overweight HIIT1: 45.0 ± 8.0
HIIT2: 39.0 ± 10.0
MICT: 41.0 ± 10.0
HIIT1: 30.8
HIIT2: 31.4 ± 5.3
MICT: 29.0 ± 2.7
6 weeks treadmill walking/running; supervised 3 days/week HIIT1: ten sets of 1-min at 90% of HRmax with walking recovery
HIIT2: four sets of 4-min at 85–95% of HRmax with 3-min recovery at 70% of HRmax
MICT (matched-work with HIIT): 45-min at 70% of HRmax
HIIT1: 10 (30)
HIIT2: 16 (48)
57 and 75 vs. 135
Boff et al. (72) 36 (male, female) HIIT
MICT
CON
Type 1 diabetes HIIT: 26.1 ± 7.8
MICT: 23.7 ± 5.8
CON: 20.8 ± 2.6
HIIT: 23.2 ± 2.4
MICT: 24.1 ± 2.0
CON: 22.7 ± 2.6
8 weeks cycling; supervised 3 days/week HIIT: 20-min at 50% of HRmax for first 2 weeks
three to six sets of 1-min at 80–85% of HRmax with 4–5 min recovery at 50% of HRmax
MICT (ND matched-work with HIIT): 20–40 min at 50 65% of HRmax
CON: walking at least three times a week for 30 min
3–6 (9–18) 18–30 vs. 20–40
Bouaziz et al. (64) 60 (male, female) HIIT
CON
Sedentary older adults HIIT: 72.9 ± 2.5
CON: 74.3 ± 3.4
HIIT: 28.7 ± 5.6
MICT: 28.8 ± 5.1
9.5 weeks cycling; supervised 2 days/week HIIT: six sets of 4-min at first ventilator threshold with 1-min recovery at 40% of first ventilator threshold
CON: sedentary lifestyle and current food habits
24 (48) NA
Chidnok et al. (65) 24 (male, female) HIIT
CON
Healthy young adults HIIT: 21.3 ± 0.7
CON: 21.3 ± 0.7
HIIT: 21.3 ± 3.9
CON: 21.3 ± 4.4
6 weeks cycling; supervised 3 days/week HIIT: five sets of 1-min at 80% of HRmax with 2-min recovery
CON: Maintained daily activities
5 (15) NA
Currie et al. (46) 22 (male, female) HIIT
MICT
Coronary artery disease HIIT: 62.0 ± 11.0
MICT: 68.0 ± 8.0
HIIT: 27.9 ± 4.9
MICT: 27.3 ± 4.2
12 weeks cycling; supervised 2 days/week HIIT: ten sets of 1-min at 89% of peak power output with 1-min recovery at 10% of peak power output
MICT (unmatched-work with HIIT): 30–50 min at 58% of peak power output
10 (20) 70 vs. 90–130
Conraads et al. (47) 200 (male, female) HIIT
MICT
Coronary artery disease HIIT: 57.0 ± 8.8
MICT: 59.9 ± 9.2
HIIT: 28.0 ± 4.4
MICT: 28.5 ± 4.3
12 weeks cycling; supervised 3 days/week HIIT: four sets of 4-min at 90–95% of HRpeak with 3-min recovery at 50–70% of HRpeak
MICT (matched-work with HIIT): 47-min at 65–75% of HRpeak
16 (48) 114 vs. 141
Ghardashi Afousi et al. (73) 75 (male, female) HIIT
MICT
CON
Type 2 diabetes HIIT: 54.8 ± 6.2
MICT: 53.1 ± 4.8
CON: 54.2 ± 5.6
HIIT: 29.4 ± 0.9
MICT: 28.9 ± 1.0
CON: 29.3 ± 1.3
12 weeks cycling; supervised 3 days/week HIIT: twelve sets of 1.5-min at 85–90% of HRmax with 2-min recovery at 55–60% of HRmax
MICT (matched-work with HIIT): 42-min at 70% of HRmax
CON: Maintained daily activities
18 (54) 186 vs. 186
Gilbertson et al. (66) 25 (female) HIIT
CON
Obese HIIT: 48.5 ± 13.7
CON: 45.7 ± 12.1
HIIT: 37.3 ± 7.2
CON: 37.8 ± 5.5
2 weeks cycling; supervised 6 days/week HIIT: ten sets of 3-min at 90% of HRmax/peak with 3-min recovery at 50% of HRmax/peak
CON: received nutrition advice
30 (180) NA
Jo et al. (48) 37 (male, female) HIIT
MICT
Hypertensive, metabolic syndrome HIIT: 49.9 ± 7.3
MICT: 51.8 ± 8.5
HIIT: 24.9 ± 2.8
MICT: 24.9 ± 3.2
8 weeks treadmill running; supervised 3 days/week HIIT: 5-min at 60% of heart rate reserve followed by three sets of 3-min at 80% of heart rate reverse with 3-min at 40% of heart rate reserve
MICT (matched-work with HIIT): 35-min at 60% of heart rate reserve
9 (27) 75 vs. 120
Klonizakis et al. (49) 22 (female) HIIT
MICT
Postmenopausal HIIT: 64.0 ± 7.0
MICT: 64.0 ± 4.0
ND 2 weeks cycling; supervised 3 days/week SIT: 10 sets of 1-min at 100% of peak power output with 1-min recovery at 30 W
MICT (unmatched-work with HIIT): 40-min at 65% of peak power output
10 (30) 78 vs. 138
Lee et al. (67) 30 (female) HIIT
CON
Breast cancer HIIT: 49.1 ± 7.9
CON: 44.7 ± 11.2
HIIT: 33.1 ± 7.6
CON: 30.1 ± 7.7
8 weeks cycling; supervised 3 days/week HIIT: seven sets of 1-min at 90% of peak power output with 2-min recovery at 30% of peak power output
CON: less than 30 min of total structured exercise per week
7 (21) NA
Malin et al. (50) 26 (male, female) HIIT
MICT
Prediabetes HIIT: 59.9 ± 7.6
MICT: 60.4 ± 8.6
HIIT: 30.9 ± 3.8
MICT: 35.6 ± 6.0
2 weeks cycling; unsupervised 6 days/week HIIT: 10 sets of 3-min at 90% of HRpeak with 3-min recovery at 50% of HRpeak
MICT (matched-work with HIIT): 60-min at 70% of HRpeak
30 (180) 360 vs. 360
Mitranun et al. (74) 45 (male, female) HIIT
MICT
CON
Type 2 diabetes HIIT: 61.2 ± 10.5
MICT: 61.7 ± 10.1
CON: 60.9 ± 9.3
HIIT: 29.6 ± 1.9
MICT: 29.4 ± 2.6
CON: 29.7 ± 1.5
12 weeks treadmill running; supervised 3 days/week HIIT: 20-min at 50% of VO2 peak for 2 weeks
four to six sets of 1-min at 80–85% of VO2 peak with 4-min recovery at 50–60% of VO2 peak
MICT (matched-work with HIIT): 20–30 min at 60–65% of VO2 peak
CON: instructed to remain sedentary
4–6 (12–18) 60–90 vs. 60–90
Moholdt et al. (51) 107 (male, female) HIIT
MICT
Myocardial infarction HIIT: 56.7 ± 10.4
MICT: 57.7 ± 9.3
HIIT: 26.8 ± 3.0
MICT: 27.2 ± 4.1
12 weeks walking/running; supervised 2 d/week; unsupervised 1 day/week HIIT: four sets of 4-min at 85–95% of HRmax with 3-min recovery at 70% of HRmax
MICT (ND matched-work with HIIT): 35-min walking, jogging, lunges and squats
16 (48) 76 vs. 120
Molmen- Hansen et al. (75) 88 (male, female) HIIT
MICT
CON
Hypertensive HIIT: 52.5 ± 7.4
MICT: 53.6 ± 6.5
CON: 51.3 ± 9.2
HIIT: 26.8 ± 4.1
MICT: 27.9 ± 3.2
CON: 28.8 ± 3.7
12 weeks uphill treadmill walking/running; supervised 3 days/week HIIT: four sets of 4-min at 85–90% of HRmax with 3-min recovery at 60–70% of HRmax
MICT (matched-work with HIIT): 47-min at 70% of HRmax
CON: standard advice for hypertension, including regular light–moderate intensity exercise
16 (48) 114 vs. 141
Munk et al. (68) 40 (male, female) HIIT
CON
Coronary artery disease HIIT: 57.0 ± 14.0
CON: 61.0 ± 10.0
HIIT: 27.1 ± 5.2
CON: 27.7 ± 4.5
6 months cycling; supervised 3 days/week HIIT: four sets of 4-min at 80–90% of HRmax with 3-min recovery at 60–70% of HRmax
CON: without any structured program
16 (48) NA
Novaković et al. (76) 30 (male, female) HIIT
MICT
CON
Repaired tetralogy of Fallot HIIT: 36.2 ± 6.8
MICT: 40.1 ± 10.4
CON: 38.4 ± 8.9
HIIT: 24.5 ± 6.2
MICT: 26.3 ± 6.0
CON: 24.4 ± 5.6
36 sessions cycling; supervised 2–3 days/week HIIT: eight sets of 1-min at 80% of HRpeak with 3-min recovery at 60% of HRpeak
MICT (matched-work with HIIT): 26-min at 70% of HRpeak
CON: regular unsupervised physical activities
8 (16–24) 84–126 vs. 82–123
Nytrøen et al. (52) 81 (male, female) HIIT
MICT
Heart transplant HIIT: 50.0 ± 12.0
MICT: 48.0 ± 14.0
HIIT: 24.8 ± 3.4
MICT: 25.6 ± 3.9
12 months cycling; supervised 2–3 days/week HIIT: four sets of 4-min at 85–95% of peak effort with 3-min recovery at 60–70% of peak effort
MICT (matched-work with HIIT): 25-min at 60–80% of peak effort
16 (32–48) 112–168 vs. 112–168
O’Brien et al. (53) 24 (male, female) HIIT
MICT
Sedentary older adults HIIT: 68.0 ± 5.0
MICT: 68.0 ± 6.0
HIIT: 25.9 ± 3.1
MICT: 25.2 ± 3.6
6 weeks cycling; supervised 3 days/week SIT: 2× 35–45 sets of 15-s at 100% of peak power output with 15-s recovery
MICT (matched-work with HIIT): 30–39 min at 60% of peak power output
17.5–22.5 (52.5–67.5) 135–165 vs. 120–147
Petrick et al. (54) 23 (male) HIIT
MICT
Obese and overweight HIIT: 39.4 ± 14.9
MICT: 35.3 ± 15.1
HIIT: 34.1 ± 4.3
MICT: 33.9 ± 2.4
6 weeks cycling; supervised 3 days/week for HIIT and supervised 5 days/week for MICT SIT: four to six sets of 30-s at 170% of maximal workload with 2-min recovery at 50 W
MICT (unmatched-work with HIIT): 30–40 min at 60% of maximal workload
2–3 (6–9) 45–60 vs. 150–200
Rakobowchuk et al. (55) 20 (male, female) HIIT
MICT
Healthy HIIT: 23.6 ± 3.2
MICT: 23.0 ± 2.4
HIIT: 23.6 ± 3.0
MICT: 24.3 ± 2.1
6 weeks cycling; supervised 3 days/week for HIIT and supervised 5 days/week for MICT SIT: four to six sets of Wingate tests with 4.5-min recovery at 30 W
MICT (unmatched-work with HIIT): 40–60 min at 65% of VO2 peak
2–3 (6–9) 43.5–76.5 vs. 200–300
Ramírez-Vélez et al. (69) 36 (male, female) HIIT
CON
Overweight with abdominal obesity HIIT: 40.8 ± 7.1
CON: 40.8 ± 7.1
HIIT: 30.0 ± 3.5
CON: 30.0 ± 3.5
12 weeks treadmill walking/running; supervised 3 days/week HIIT: four sets of 4-min at 85–95% of HRmax with 4-min recovery at 65% of HRmax
CON: received nutritional advice
16 (48) NA
Ramírez-Vélez et al. (56) 21 (ND) HIIT
MICT
Sedentary adults HIIT: 18−45
MICT: 18−45
HIIT: 25.5 ± 4.2
MICT: 23.6 ± 3.6
12 weeks treadmill walking/running; supervised and unsupervised 3 days/week HIIT: four sets of 4-min at 85–95% of heart rate reverse with 4-min recovery at 75–85% of heart rate reserve
MICT (matched-work with HIIT): 30–35 min at 60–75% of heart rate reserve
16 (48) 114–126 vs. 132–147
Sarvasti et al. (57) 11 (male, female) HIIT
MICT
Coronary artery disease HIIT: 48.5 ± 6.6
MICT: 48.5 ± 6.6
HIIT: 27.0 ± 3.9
MICT: 27.0 ± 3.9
2 weeks treadmill walking; supervised 3 days/week HIIT: four sets of 4-min at 60–80% of heart rate reverse with 3-min recovery at 40–50% of heart rate reserve
MICT (matched-work with HIIT): 29-min at 40–60% of heart rate reserve
16 (48) 99 vs. 111
Sawyer et al. (58) 22 (male, female) HIIT
MICT
Obese HIIT: 35.1 ± 8.1
MICT: 35.1 ± 8.1
HIIT: 37.4 ± 6.2
MICT: 34.5 ± 3.2
8 weeks cycling; supervised 3 days/week HIIT: ten sets of 1-min at 90–95% of HRmax with 1-min recovery at 25–50 W
MICT (not matched-work with HIIT): 30-min at 70–75% of HRmax
10 (30) 87 vs. 120
Schjerve et al. (59) 27 (male, female) HIIT
MICT
Obese HIIT: 46.9 ± 8.2
MICT: 44.4 ± 7.6
HIIT: 36.6 ± 4.5
MICT: 36.7 ± 5.0
12 weeks walking/jogging; supervised 2 days/week; unsupervised 1 day/week HIIT: four sets of 4-min at 85–95% of HRmax with 3-min recovery at 50–60% of HRmax
MICT (matched-work with HIIT): 47-min at 60–70% of HRmax
16 (48) 120 vs. 141
Stensvold et al. (70) 22 (male, female) HIIT
CON
Metabolic syndrome HIIT: 49.9 ± 10.1
MICT: 47.3 ± 10.2
HIIT: 31.3 ± 4.3
MICT: 31.9 ± 4.1
12 weeks treadmill walking/running; supervised 3 days/week HIIT: four sets of 4-min at 90–95% of HRpeak with 3-min recovery at 70% of HRpeak
CON: instructed not to change their dietary patterns or physical activity
16 (48) NA
Taylor et al. (60) 54 (male, female) HIIT
MICT
Coronary artery disease HIIT: 64.0 ± 8.0
MICT: 63.0 ± 8.0
HIIT: 28.7 ± 4.3
MICT: 29.5 ± 4.2
4 weeks walking/running or cycling/elliptical; supervised 2 days/week; unsupervised 1 day/week HIIT: four sets of 4-min at 85–95% of HRpeak with 3-min recovery
MICT (ND matched-work with HIIT): 40-min at 65–75% of HRpeak
16 (48) ND
Thijssen et al. (61) 24 (male, female) HIIT
MICT
Heart failure HIIT: 63.0 ± 8.0
MICT: 64.0 ± 8.0
HIIT: 28.1 ± 7.5
MICT: 28.9 ± 4.7
12 weeks cycling; supervised 3 days/week HIIT: ten sets of 1-min at 90% of maximal workload by 2.5-min recovery at 30% of maximal workload
MICT (matched-work with HIIT): 30-min at 60–75% of maximal workload
10 (20) 70 vs. 60
Tjønna et al. (77) 32 (male, female) HIIT
MICT
CON
Metabolic syndrome HIIT: 55.3 ± 13.2
MICT: 52.0 ± 10.6
CON: 49.6 ± 9.0
HIIT: 29.8 ± 5.5
MICT: 29.4 ± 4.9
CON: 32.1 ± 3.3
16 weeks uphill treadmill walking/running; supervised 3 days/week HIIT: four sets of 4-min at 90% of maximal heart rate with 3-min recovery at 70% of maximal heart rate
MICT (matched-work with HIIT): 47-min at 70% of maximal heart rate
CON: advice from family physicians
16 (48) 120 vs. 141
Tucker et al. (78) 29 (male) HIIT
MICT
CON
sedentary inactive HIIT: 30.0 ± 7.0
MICT: 29.0 ± 7.0
CON: 28.0 ± 9.0
HIIT: 30.2 ± 3.0
MICT: 29.7 ± 4.5
CON: 29.6 ± 3.9
4 weeks cycling; supervised 4 days/week HIIT: eight to eleven sets of 1-min at 90–95% of HRmax with 1-min recovery
MICT (matched-work with HIIT): 30–45 min at 50% of VO2 max
CON: instructed to maintain their current physical activity pattern
8–11 (32–44) 100–128 vs. 160–220
Turri-Silva et al. (71) 18 (male, female) HIIT
CON
Heart failure HIIT: 60.9 ± 9.7
CON: 56.0 ± 9.7
HIIT: 29.4 ± 5.2
CON: 28.6 ± 4.5
12 weeks cycling/running; supervised 3 days/week HIIT: four sets of 3-min at high intensity with 4-min recovery at moderate intensity
CON: maintained daily activities
12 (36) NA
Wisløff et al. (79) 27 (male, female) HIIT
MICT
CON
Heart failure HIIT: 76.5 ± 9.0
MICT: 74.4 ± 12.0
CON: 75.5 ± 13.0
HIIT: 24.5 ± 3.0
MICT: 24.7 ± 3.0
CON: 25.5 ± 2.0
12 weeks uphill treadmill walking; supervised 2 days/week; unsupervised 1 days/week HIIT: four sets of 4-min at 90–95% of HRpeak with 3-min recovery at 50–70% of HRpeak
MICT (matched-work with HIIT): 47-min at 70–75% of HRpeak
CON: one exercise session every 3 weeks
16 (48) 114 vs. 141

HIIT, high-intensity interval training; MICT, moderate-intensity continuous training; CON, control; VO2 max/peak, maximal or peak oxygen uptake; HRmax/peak, maximal or peak heart rate; W, watt; ND, not-described; NA, not-available.